ETIDIOH - NEW: pandemic influenza

Showing posts with label pandemic influenza. Show all posts

Saturday, October 17, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 17 '26)

Epidemiol Infect

ONTAS E
Establishing influenza epidemic thresholds and intensity levels in Turkiye using the moving epidemic method and assessing concordance with WHO transmission zones: A sentinel surveillance analysis of ten seasons, 2013-2025.
Epidemiol Infect. 2026;154:e129.
PubMed Abstract available
KUMBAROFF Z, Harvey EP, Whitehead J, O'Neale DRJ, et al
Ethnic inequities in mathematical models for respiratory infectious disease: A systematic review.
Epidemiol Infect. 2026;154:e130.
PubMed Abstract available
HAUSER-VAN WESTRHENEN ESEM, De Hoog MLA, Winkel AMAM, Junquera Guinovart L, et al
Viral interference with SARS-CoV-2 during the COVID-19 pandemic: An individual participant data meta-analysis.
Epidemiol Infect. 2026;154:e128.
PubMed Abstract available
TRIGO F, Guillen JM, Hernandez-Barrera V, Gil R, et al
Burden of RSV hospital disease and its comorbidities in adults in Spain (2016-2023).
Epidemiol Infect. 2026;154:e127.
PubMed Abstract available
PILAPIL JD, Mata MA, Del Rosario R, Pasciolco MJ, et al
Genomic surveillance of COVID-19 in Hong Kong (2020-2023): Analysing SARS-CoV-2 variants, mutations, and their impact on viral entry.
Epidemiol Infect. 2026;154:e124.
PubMed Abstract available
SPRONK M, Boyd A, Campman SL, Jongen V, et al
Presence of post-COVID-19 condition in six ethnic groups in Amsterdam, the Netherlands: a retrospectively reconstructed time interval approach.
Epidemiol Infect. 2026;154:e121.
PubMed Abstract available

J Clin Microbiol
HEIMSCH KC, Stanoeva KR, Visser I, Rahou Y, et al
SARS-CoV-2 and RSV external quality assessment on molecular detection and variant typing in European expert laboratories in 2025.
J Clin Microbiol. 2026;64:e0025826.
PubMed Abstract available
SMITH K, Martinez J, Yu H, Harrison J, et al
Development and evaluation of an ARTIC-based amplicon sequencing assay for whole-genome characterization of respiratory syncytial virus.
J Clin Microbiol. 2026;64:e0046826.
PubMed Abstract available

J Immunol
KOUTSAKOS M, Crawford JC, Grzelak L, Rizzetto S, et al
TCRalphabeta repertoire plasticity defines universal CD8+ T cell responses directed at influenza-specific HLA-A*02:01-PB1413-421 epitope.
J Immunol. 2026;215:vkag270.
PubMed Abstract available

J Infect Dis
BAI X, Chen S, Yin S, Zhao Q, et al
Characterization of Mucosal BPI fold-containing family A member 1-High-Expressing Neutrophils and their Immune Defense roles in Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection via single-cell RNA sequencing.
J Infect Dis. 2026;234:583-593.
PubMed Abstract available
NARAYAN K, Tosh K, Holmes A, Hu L, et al
Serum Virus-Neutralizing Antibody Titers in Clinical Trial Participants With and Without Immunocompromise Receiving Pemivibart, a Long-Acting Monoclonal Antibody for COVID-19.
J Infect Dis. 2026;234:e859-e868.
PubMed Abstract available
AVADHANULA V, Bournat J, Ferlic-Stark LL, Bond NL, et al
Impact of Low Community Circulation of Respiratory Syncytial Virus (RSV) on Immunity Debt Against RSV in Adults During the Coronavirus Disease 2019 Pandemic.
J Infect Dis. 2026;234:564-572.
PubMed Abstract available
SUTCLIFFE CG, Sergent VM, Yazzie D, Brasinikas G, et al
Post-COVID Rebound in Invasive Pneumococcal Disease Driven by Resurgence of Serotype 4 Among American Indian Individuals in the Southwest United States.
J Infect Dis. 2026;234:e908-e921.
PubMed Abstract available
MOORE HC, Foo D, Giannini F, Minney-Smith C, et al
What is the Optimal RSV Immunization Strategy for Infants Born in the RSV Off-season?
J Infect Dis. 2026;234:e823-e828.
PubMed Abstract available
EPSI NJ, Richard SA, Morris MJ, Lindholm DA, et al
Is Cellular Senescence a Biological Feature of Long COVID? A Transcriptomic Analysis Across Comparative Postacute Sequelae Phenotypes.
J Infect Dis. 2026;234:e869-e880.
PubMed Abstract available
PEREZ-GARCIA C, Llorente J, Aguirre Alastuey ME, Llamosi M, et al
Lineage Dynamics and Risk Factors Underlying Serotype 4 Invasive Pneumococcal Disease in Spain.
J Infect Dis. 2026;234:e922-e934.
PubMed Abstract available
WAN T, Lautenbach E, Mannathoko N, Mosepele M, et al
Diverse genetic lineages spreading across healthcare and community boundaries underlie extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) colonization burden in Botswana.
J Infect Dis. 2026 Jul 7:jiag342. doi: 10.1093.
PubMed Abstract available
LEIS AM, Han JH, Hough CL
Beyond the Acute Illness: Three Myths About Viral Respiratory Infection.
J Infect Dis. 2026;234:513-515.
PubMed Abstract available

J Virol
WILLIAMS SL, Gygli SM, Bjorgen JC, Fan H, et al
Avian influenza A virus polymerase gene leads to temperature-resistant genome replication.
J Virol. 2026 Oct 13:e0097826. doi: 10.1128/jvi.00978.
PubMed Abstract available

PLoS Biol
NIU C, Huang X, Yan Q, Liu B, et al
R1-32-like public antibodies acquire tolerance to SARS-CoV-2 antigenic drift through somatic hypermutation.
PLoS Biol. 2026;24:e3003996.
PubMed Abstract available

PLoS One
BHUKHAI K, Tanhuad N, Srimorkun P, Manopwisedjaroen S, et al
Omicron SARS-CoV-2 shows NRP1-linked susceptibility in adipose-derived MSCs and alters primitive cord blood CD34(+) HSPCs.
PLoS One. 2026;21:e0360439.
PubMed Abstract available
SADIQ M, Wasim B, Khatoon A, Kumar A, et al
Whole-exome sequencing identifies a missense variant in the cytoskeletal gene SVIL implicating actin remodeling in COVID-19 severity in a Pakistani cohort.
PLoS One. 2026;21:e0360429.
PubMed Abstract available
REZENDE LMT, Silva KVC, Cuadro A, Signes VM, et al
Consequences of COVID-19 infection on educators' executive functions: A systematic review and meta-analysis protocol.
PLoS One. 2026;21:e0350156.
PubMed Abstract available
LI X, Ding J, Zhang Y, Hu T, et al
Measuring destination image dissonance: A compositional data analysis of cross-media representations in Sanya's Tourism.
PLoS One. 2026;21:e0360383.
PubMed Abstract available
YANG Y, Juntila-Raymond C, Callear A, Smith M, et al
Evaluation of pre-Omicron population immunity for SARS-CoV-2 in the Household Influenza Vaccine Evaluation (HIVE) cohort.
PLoS One. 2026;21:e0360506.
PubMed Abstract available
VERFAILLIE SCJ, Verveen A, Visser D, Nieuwkerk P, et al
Post-acute sequelae of COVID-19 (PASC) are associated with distinct clinical phenotypes two years after SARS-CoV-2 infection: A data-driven approach.
PLoS One. 2026;21:e0359844.
PubMed Abstract available
NGAMALEU MR, Tene H, Djounda R, Minomo R, et al
Early inflammation-driven damage and delayed viral clearance are associated with prolonged biliary perturbation in a Cameroonian cohort of COVID-19 patients.
PLoS One. 2026;21:e0357503.
PubMed Abstract available
JUNG H, Jung M
A retrospective epidemiological study of screening-derived solid cancer incidence proxy rates in South Korea before and after COVID-19 using Korean National Health Insurance Service data.
PLoS One. 2026;21:e0360040.
PubMed Abstract available

Vaccine
BOER M, Klugkist I, Kroese F
Educational background and vaccination beliefs in the Netherlands: A Bayesian Evidence Synthesis from four studies.
Vaccine. 2026;93:129132.
PubMed Abstract available
SAIKI S, Kuroiwa M, Hashimoto K, Nakajima-Yoshida H, et al
LP.8.1-directed recombinant protein COVID-19 vaccine S-268025, formulated with squalene-based adjuvant A-910823, elicits robust immunogenicity and neutralizing breadth in mice.
Vaccine. 2026;93:129177.
PubMed Abstract available
BAZARJAV P, Erdene-Ochir T, Sandagdorj A, Enkhtuvshin A, et al
One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia.
Vaccine. 2026;93:129179.
PubMed Abstract available
GOULD S, Rohde CM, Destexhe E, Tiesjema B, et al
Summary of 2025 Society of Toxicology Workshop "Vaccine Toxicology in the Post-COVID Era".
Vaccine. 2026;93:129180.
PubMed Abstract available
BRADY C, Govender M, Mellors J, Tipton T, et al
Spike antibody Fc is associated with protection from SARS-CoV-2 challenge in macaques.
Vaccine. 2026;93:129192.
PubMed Abstract available
SHICHINOHE S, Li Q, Tanaka H, Anindita J, et al
Cross-clade protection against human H5N1 isolates by a clade 2.3.4.4b HA mRNA vaccine in mice.
Vaccine. 2026;93:129215.
PubMed Abstract available
BEOGO I, Xu Y, Kibret TC, Muray M, et al
Perception of COVID-19 vaccine effectiveness perception in older racialized communities: role of major racial discrimination and health literacy.
Vaccine. 2026;93:129214.
PubMed Abstract available
BEOGO I, Kibret TC, Zhang Q, Muray M, et al
Ethnic disparities in COVID-19 vaccine uptake among among 55+ year-old Canadians: Exploring the role of racial discrimination, chronic disease comorbidities, and conspiracy beliefs.
Vaccine. 2026;93:129213.
PubMed Abstract available
KOPP L, Hofner B, Mentzer D
Mobile-app-based cohort event monitoring study (CEM) of COVID-19 vaccines.
Vaccine. 2026;93:129219.
PubMed Abstract available
MARQUES DFP, Howard J, Alvarez ML, Machado A, et al
Comparing two case definitions for including severe acute respiratory infection patients in influenza and COVID-19 vaccine effectiveness studies among older adults using the test-negative design: VEBIS hospital network, seven European countries, 2023/
Vaccine. 2026;94:129234.
PubMed Abstract available

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.

The #Risk of an #H5N1 #Influenza #Pandemic

Abstract

The last 110 years have seen four influenza A pandemics, where viruses have emerged from mammals or birds with the ability to transmit and cause disease in human populations. Since 2021, a high-pathogenicity strain of avian influenza, H5N1, has caused a panzootic (pandemic of animals), with global spread in wild birds, resulting in frequent spillovers into farmed poultry and into mammals, including mammal species not previously known to be affected by influenza A. This has created increased opportunity for reassortment, mutation, human infection, and potential adaptation to transmit. The risk to humans and the impact are difficult to quantify but of mounting concern to public health bodies. Here, we examine the risk of an H5N1 pandemic emerging and spreading in humans and the potential impact of an H5N1 pandemic.

Source:

Link: https://doi.org/10.1146/annurev-med-042525-092552

____

Giuseppe Michieli

Saturday, October 10, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 10 '26)

Antimicrob Agents Chemother

LIU S, Qiu X, Guo S, Wang L, et al
Mechanistic blockade of RSV infection by a pre-F targeting single-domain antibody-Fc fusion protein.
Antimicrob Agents Chemother. 2026;70:e0054126.
PubMed Abstract available

BMC Pediatr
APPEL S, Coughtrey AE, Kyrdalen A, Takeda A, et al
Understanding heterogeneity in paediatric long COVID research: an overview of reviews and recommendations for future pandemics.
BMC Pediatr. 2026;26:937.
PubMed Abstract available

J Immunol
SEGARD A, Goguet E, Haines-Hull H, Williamson KC, et al
Effects of natural killer cell depletion on innate and adaptive immune responses to COVID mRNA vaccination.
J Immunol. 2026;215:vkag266.
PubMed Abstract available

J Infect Dis
Correction to: Introduction and Update: Advances in Influenza Therapeutics.
J Infect Dis. 2026 Oct 8:jiag499. doi: 10.1093.
PubMed

J Virol
CIACCI ZANELLA G, Vincent ML, Flores L, Aljets EK, et al
A multivalent mRNA-lipid nanoparticle vaccine containing eight hemagglutinin antigens elicited broad neutralizing antibody responses and protected against influenza A virus challenge in swine.
J Virol. 2026 Oct 9:e0084826. doi: 10.1128/jvi.00848.
PubMed Abstract available
SOUZA CK, Santos JJS, Boggiatto P, Sterle H, et al
H5 influenza virus mRNA-lipid nanoparticle (LNP) vaccination elicits adaptive immune responses in Holstein calves.
J Virol. 2026 Oct 8:e0128926. doi: 10.1128/jvi.01289.
PubMed Abstract available
DEL ROSARIO JMM, van Diemen PM, Frost SDW, Vishwanath S, et al
A digitally immune-optimized influenza vaccine broadly neutralizes swine and human H1N1 influenza viruses and protects from heterologous challenge.
J Virol. 2026 Oct 6:e0107326. doi: 10.1128/jvi.01073.
PubMed Abstract available
NOORUZZAMAN M, Buchholz DW, Rani R, de Oliveira PSB, et al
Infection and transmission dynamics of bovine and human influenza A H5N1 viruses in mouse and hamster models.
J Virol. 2026 Oct 6:e0104426. doi: 10.1128/jvi.01044.
PubMed Abstract available

PLoS One
ZAIR X, Wilm A, Benton MC, Tham CY, et al
Sub-consensus haploid variant calling in long-read sequencing technology.
PLoS One. 2026;21:e0356259.
PubMed Abstract available
RAMIREZ-SOTO MC, Arroyo-Hernandez H, Machuca JVB, Stalder DH, et al
Pneumonia incidence, hospitalizations and mortality before and during the COVID-19 pandemic in Peru: An observational study.
PLoS One. 2026;21:e0351171.
PubMed Abstract available
YEO D, Woo S, Kim J, Kim K, et al
Exposure to residential greenness and subsequent risk of common mental disorders among individuals with COVID-19 in South Korea: A nationwide cohort study.
PLoS One. 2026;21:e0359016.
PubMed Abstract available
ANGRISANI M, Atella V, Bruine de Bruin W, Kopinska J, et al
How personality traits shape susceptibility to mental distress in times of crisis: Evidence from the COVID-19 pandemic.
PLoS One. 2026;21:e0358371.
PubMed Abstract available
PENG Q, Wu M, Feng Q
Service-oriented reallocation and value-added intensity in China's sport industry, 2018-2024: A longitudinal accounting analysis.
PLoS One. 2026;21:e0354049.
PubMed Abstract available
POQUET D, Le Gal C, Hincker P, Beghin L, et al
Reach and engagement in the ECAIL trial targeting socially disadvantaged families across the COVID-19 pandemic and cost-of-living crisis: A mixed-methods implementation study.
PLoS One. 2026;21:e0350372.
PubMed Abstract available
KANMA-OKAFOR OJ, Ravi P, Ngaybe MGB, Yusoof K, et al
Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol.
PLoS One. 2026;21:e0358599.
PubMed Abstract available
MYAT KYAW HM, Li Y, Chan DKC, Capio CM, et al
COVID-19 infection and Hong Kong elementary children's Chinese and English reading proficiencies: Parent-reported proficiency versus performance-based reading tests.
PLoS One. 2026;21:e0359793.
PubMed Abstract available
GUMMER T, Lu KH, von Glasenapp K
Assessing the FAIRness of survey data collected during the COVID-19 pandemic in Germany.
PLoS One. 2026;21:e0358755.
PubMed Abstract available

Proc Natl Acad Sci U S A
ALSTON H, Mora T, Walczak AM
Neutralization titers reveal the structure of polyclonal antibody responses.
Proc Natl Acad Sci U S A. 2026;123:e2612096123.
PubMed Abstract available

Vaccine
JEONG O, Kim PK, Oh H, Lee K, et al
Sequence-Aware Antigenic Alignment and SRID Potency Interpretation in Influenza Vaccines.
Vaccine. 2026;93:129191.
PubMed Abstract available

Giuseppe Michieli

Saturday, October 3, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 3 '23)

Antiviral Res

MA S, Chen Y, Zhu J, Zong Y, et al
N70S/Y155H Combined Mutation of Neuraminidase of Avian Influenza H9N2 Virus confers oseltamivir and zanamivir resistance and pathogenicity to Mice.
Antiviral Res. 2026 Sep 29:106540. doi: 10.1016/j.antiviral.2026.106540.
PubMed Abstract available

J Infect

NAZARETH J, Martin CA, Pan D, Barr IG, et al
Ethnic differences in inactivated influenza vaccine immunogenicity in UK Healthcare Workers: A two-year prospective longitudinal study.
J Infect. 2026 Sep 29:106862. doi: 10.1016/j.jinf.2026.106862.
PubMed Abstract available

DUAN Q, Jin X, Fu X, Zhu A, et al
Household transmission dynamics of human respiratory syncytial virus in China: A multicentre epidemiological and molecular study.
J Infect. 2026;93:106834.
PubMed Abstract available

ZHOU S, Liu C, Liu W, Cai K, et al
Cross-Neutralizing Antibody Responses to Diverse Coronaviruses in the Human Population.
J Infect. 2026 Aug 11:106827. doi: 10.1016/j.jinf.2026.106827.
PubMed Abstract available

LI X, Mercade-Besora N, Lam AS, Barboza C, et al
Effectiveness and waning of the fourth dose mRNA COVID-19 vaccines for the prevention of SARS-CoV2 infection related hospitalisations and deaths.
J Infect. 2026 Aug 5:106825. doi: 10.1016/j.jinf.2026.106825.
PubMed Abstract available

QUINOT C, Lunt R, Kirsebom F, Andrews N, et al
Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England.
J Infect. 2026;93:106819.
PubMed Abstract available

MMWR Morb Mortal Wkly Rep

KYAW NTT, Foote MMK, Lo Piccolo AJ, Wallach AB, et al
Unannounced Drills Using Patient Actors to Evaluate Health Care Facility Readiness for Infectious Disease Outbreaks - New Jersey, New York, and U.S. Virgin Islands, January-June 2026.
MMWR Morb Mortal Wkly Rep. 2026;75:581-587.
PubMed Abstract available

Pediatrics

FRINTNER MP, Freed GL, Byrne BJ, Gottschlich EA, et al
Pediatrician Burnout Over Time: 2021-2025.
Pediatrics. 2026;158:e2026076643.
PubMed Abstract available

PLoS Biol

DAILEY KE, Wang Y, Teo QW, Wang C, et al
Epistasis and pleiotropy constrain the evolution of cross-reactive breadth in a broadly neutralizing influenza antibody.
PLoS Biol. 2026;24:e3004021.
PubMed Abstract available

PLoS Comput Biol

LEMAITRE J, Lessler J
Generative diffusion models for spatiotemporal influenza forecasting.
PLoS Comput Biol. 2026;22:e1014846.
PubMed Abstract available

PLoS One

LI Q, Bond RM, Nisbet E, Dixon G, et al
The limited effects of social media use on misperceptions Social media's limited role in misperceptions.
PLoS One. 2026;21:e0354486.
PubMed Abstract available

RICO-BOLIVAR DL, Diaz-Brochero C, Hattemer R, Bejarano-Mora CA, et al
Causes of hospitalization among people living with HIV in a tertiary-care hospital in Bogota, Colombia, 2018-2024.
PLoS One. 2026;21:e0357788.
PubMed Abstract available

DUCHOWNY K, Wang V, Noppert G, Melendez R, et al
Essential work, unequal places: Neighborhood characteristics of the essential workforce in the United States during the COVID-19 pandemic.
PLoS One. 2026;21:e0357792.
PubMed Abstract available

DE ANDA-JAUREGUI G, Sifuentes-Osornio J, Angulo-Guerrero O, Diaz-De-Leon-Santiago JL, et al
Complexity of hospital demand during the COVID-19 pandemic in Mexico City.
PLoS One. 2026;21:e0358798.
PubMed Abstract available

NEVES RKAD, Bastos LS, Maciel Villela DA, Saraceni V, et al
Rehospitalization due to COVID-19 reinfection in Rio de Janeiro, 2020-2022: Associations with vaccination status, sociodemographic and clinical factors.
PLoS One. 2026;21:e0332281.
PubMed Abstract available

BABAZADEH SHAREH M, Kleiner F, Bohme M, Hagele C, et al
Automated model discovery based on COVID-19 epidemiological data from Thuringia, Germany.
PLoS One. 2026;21:e0344409.
PubMed Abstract available

ONYANGO EO, Kiplagat J, Gokiert R, Owuor PM, et al
An intersectionality-based policy analysis of COVID-19 measures and women informal food vendors in Kisumu, Kenya.
PLoS One. 2026;21:e0359620.
PubMed Abstract available

MESQUITA S, Loureiro J, Haupt Vieira C, Perfeito L, et al
Learning from pandemics: Feature selection and clustering for robust digital disease nowcasting.
PLoS One. 2026;21:e0358063.
PubMed Abstract available

ABI ZEID B, El Khoury T, Abdulrahim S, Ghattas H, et al
Predicting COVID-19 infection among older Syrian refugees in Lebanon: A multi-wave survey.
PLoS One. 2026;21:e0359272.
PubMed Abstract available

BOZDECH M
Rising performance-efficiency demands in female junior tennis: A longitudinal analysis of ITF World Tennis Tour Juniors rankings, 2004-2025.
PLoS One. 2026;21:e0359538.
PubMed Abstract available

JOHNSON G, Edwards S, Jarman H, Peel E, et al
Understanding delivery of bad news in the emergency department: A scoping review.
PLoS One. 2026;21:e0358343.
PubMed Abstract available

Proc Natl Acad Sci U S A

DUDLEY C, Magdaleno R, Harding C, Sharma A, et al
Mantis: A foundation model for mechanistic disease forecasting.
Proc Natl Acad Sci U S A. 2026;123:e2602542123.
PubMed Abstract available

Vaccine

NIAN H, Ding T, Lee RL, Gebretsadik T, et al
COVID-19 vaccine uptake among individuals with Down syndrome in the Unites States.
Vaccine. 2026;92:129128.
PubMed Abstract available

OKHOLM AK, Fougeroux C, Hagen SH, Paludan SR, et al
Virus-like particle display of the SARS-CoV-2 receptor-binding domain using a modular tag/catcher system enhances immunogenicity of a DNA vaccine in mice.
Vaccine. 2026;92:129117.
PubMed Abstract available

C M, Dymock M, Flanagan KL, Plebanski M, et al
The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.
Vaccine. 2026;92:129034.
PubMed Abstract available

ONISHI S, Suzuki Y, Sugimoto K, Otsuka A, et al
Improving intradermal dosing consistency in mice using a hollow microneedle: A model study with a SARS-CoV-2 mRNA vaccine.
Vaccine. 2026;92:129111.
PubMed Abstract available

ALMEIDA MG, Alves de Oliveira BF, de Melo Junior EB, de Araujo Rodrigues AR, et al
Knowledge as a predictor of parental vaccine hesitancy during children's first year of life.
Vaccine. 2026;92:129127.
PubMed Abstract available

DESAI M, Cardona J, Khetan S, Mehta S, et al
Safety and immunogenicity of mRNA-1345 revaccination at least 12 months following primary vaccination with a licensed protein subunit RSV vaccine.
Vaccine. 2026;92:129068.
PubMed Abstract available

BLANCHARD C, Myers J, McNabb AL, Lee YA, et al
Evaluating access to COVID-19 vaccines for children and adolescents in North Carolina through community pharmacies, 2021-2023.
Vaccine. 2026;92:129125.
PubMed Abstract available

FORR A, Salmon DA, Markalanda SH, Joseph A, et al
Promoting a personalized vaccine information website through social media and local outreach: a dissemination and implementation study.
Vaccine. 2026;92:129161.
PubMed Abstract available

HYDER S, Melchinger H, Malik F, Kuppalli K, et al
Trust in government institutions and influenza vaccine acceptance among U.S. adults.
Vaccine. 2026;93:129212.
PubMed Abstract available

TSOU TP, Huang YT, Lin CY, Chu PW, et al
Influenza vaccine effectiveness against influenza-related medical visits, hospitalization and death among adults aged 65 years and older in Taiwan: interim 2024-2025 season result using standard-dose inactivated influenza vaccine.
Vaccine. 2026;93:129165.
PubMed Abstract available

JAYASHANKAR L, DeGrace M, Treanor J, Swanson NJ, et al
Protection Before Day One: advancing broadly protective seasonal influenza vaccines with pandemic coverage.
Vaccine. 2026;93:129188.
PubMed

Giuseppe Michieli

Saturday, September 26, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 26 '26)

Arch Virol

LEE K, An SH, Heo GB, Lee YJ, et al
Correction: Genomic characterization of H6N1 avian influenza viruses from wild birds and domestic ducks in the republic of Korea and Mongolia (2022-2024).
Arch Virol. 2026;171:283.
PubMed

Biochem Soc Trans

CAWTHORNE W, Zhang Y, Val N, Nelson M, et al
Unmasking programmed cell death in rhinovirus-driven asthma pathology.
Biochem Soc Trans. 2026;54:1359-1373.
PubMed Abstract available

BMC Pediatr

SU L, Chen HS, Qiu WL, Zhong WM, et al
The rationality of drug treatment and clinical characteristics in children with SARS-CoV-2 infection: a retrospective analysis.
BMC Pediatr. 2026;26:894.
PubMed Abstract available

Epidemiol Infect

MITCHELL E, Zhu H, Fitzpatrick T, Majoe A, et al
Social disparities and the COVID-19, influenza, and RSV 'tripledemic' in Ontario, Canada: A population-based study.
Epidemiol Infect. 2026;154:e117.
PubMed Abstract available

Eur J Epidemiol

ANDREASSON J, Bennet L, Bjork J, Dietler D, et al
SARS-CoV-2 infection as a trigger of type 2 diabetes in adults: a population-based cohort study in Sweden using a double negative control design.
Eur J Epidemiol. 2026;41:959-967.
PubMed Abstract available

HELLE S, Tanskanen AO, Danielsbacka M
The decade of double-trouble: live birth and stillbirth sex ratio variation in Finland during the COVID-19 pandemic and Russia's attack on Ukraine.
Eur J Epidemiol. 2026;41:1019-1028.
PubMed Abstract available

J Infect Dis

SCHUMER C, Mann AJ, Fourati S, Lukas P, et al
Viral Dynamics of the Respiratory Syncytial Virus During Experimental Human Challenge: Implication for Transmission and Protection.
J Infect Dis. 2026;234:407-416.
PubMed Abstract available

ALKARKOUKLY S, Hambo S, Menk M, Spieth P, et al
Regulatory T-Cell Notch4 Expression Correlates With Mortality in Patients Hospitalized With COVID-19.
J Infect Dis. 2026;234:396-406.
PubMed Abstract available

ENGELMANN I, Pisoni A, Mille C, Ayadi M, et al
Age-Dependent Clinical and Molecular Rhinovirus Epidemiology, 2018-2023.
J Infect Dis. 2026;234:417-426.
PubMed Abstract available

MCCULLOCH DJ, Khawaja F, Tverdek FP, Ford ES, et al
First Report on Remdesivir Use for the Treatment of Respiratory Syncytial Virus in Five Allogeneic Hematopoietic Cell Transplant Recipients.
J Infect Dis. 2026;234:e552-e555.
PubMed Abstract available

MARCHAL A, Kerdiles T, Perrin A, Gervais A, et al
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.
J Infect Dis. 2026;234:e515-e521.
PubMed Abstract available

ROEN AO, Hedberg P, Pereira JPV, Zazzi M, et al
Increased In-Hospital Mortality in Immunocompromised Individuals Hospitalized With COVID-19 During the Global Pandemic: A Multinational Cohort Study in the EuCARE Project.
J Infect Dis. 2026;234:e496-e505.
PubMed Abstract available

FREYN AW, Budigi Y, Girard B, Santos G, et al
Cell-Mediated Immunity of mRNA-1283 Vaccine Encoding SARS-CoV-2 Spike Receptor-Binding and N-Terminal Domains in Preclinical and Clinical Studies.
J Infect Dis. 2026 Jun 4:jiag248. doi: 10.1093.
PubMed Abstract available

J Virol

ZHANG L, Chen N, Eichmann A, Nehlmeier I, et al
The conserved QTQTX motif in the SARS-CoV-2 spike protein is dispensable for cleavage and lung cell entry of the emerging variant BA.3.2.
J Virol. 2026 Aug 5:e0069126. doi: 10.1128/jvi.00691.
PubMed Abstract available

RIOS CARRASCO M, Guerreiro Cabana MF, Kovacs E, Ducarne Z, et al
Acquisition of specific human respiratory tract binding by 2.3.4.4b H5N1 hemagglutinins requires multiple mutations.
J Virol. 2026;100:e0106526.
PubMed Abstract available

KUMAR S, Lai L, Ellis ML, Patel A, et al
Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine doses.
J Virol. 2026 Aug 26:e0074926. doi: 10.1128/jvi.00749.
PubMed Abstract available

STADLER E, Mordant F, Gartner M, Docken SS, et al
Reconciliation of titer differences between SARS-CoV-2 neutralizing antibody assays.
J Virol. 2026 Aug 27:e0082326. doi: 10.1128/jvi.00823.
PubMed Abstract available

LIU G, Chen J, Wu F, Wei P, et al
Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects.
J Virol. 2026 Aug 28:e0059926. doi: 10.1128/jvi.00599.
PubMed Abstract available

XIE E, Schubert M, Reeb J, Seligmann B, et al
Arp2/3 complex-dependent actin remodeling is required for efficient RSV uncoating in A549 cells.
J Virol. 2026;100:e0111726.
PubMed Abstract available

ULLAH R, Chen W, Zhang L, Guo C, et al
Interaction between DEAD-box RNA helicase 10 and influenza PB1 polymerase selectively regulates influenza A virus replication.
J Virol. 2026 Sep 22:e0081526. doi: 10.1128/jvi.00815.
PubMed Abstract available

LEMUS-REYES JI, Fernandez-Quintero ML, Ayala E, Swanson OM, et al
Antigenic and structural analysis of the influenza hemagglutinin lateral patch.
J Virol. 2026 Sep 23:e0126526. doi: 10.1128/jvi.01265.
PubMed Abstract available

PARK H-S, Matsuoka Y, Santos C, Duncan EF, et al
Co-administration of intranasal parainfluenza virus vaccines expressing antigenically distinct SARS-CoV-2 S antigens elicits broad and durable immunity in hamsters.
J Virol. 2026 Sep 24:e0093826. doi: 10.1128/jvi.00938.
PubMed Abstract available

PLoS One

SODERSTROM LINDSTROM H, Norstrom SH, Tang C, Lindberg RH, et al
Occurrence of influenza antivirals and resistance development in influenza A viruses in aquatic environments: A risk assessment.
PLoS One. 2026;21:e0358447.
PubMed Abstract available

OHLSON A, Rehn M, Kuhlmann Berenzon S, Sturegard E, et al
Evaluation of wastewater SARS-CoV-2 surveillance for monitoring COVID-19 trends and early warning in Sweden, 2023-2024.
PLoS One. 2026;21:e0358326.
PubMed Abstract available

VAN KOEVERING K, Hong Y, Kleinberg J
Social tectonics: Rapid organization of online COVID communities.
PLoS One. 2026;21:e0355369.
PubMed Abstract available

VARGA C
Spatiotemporal clustering of highly pathogenic avian influenza (HPAI) H5N1 at the wild waterfowl-poultry interface: Vector-specific spillover risks in the U.S., 2022-2025.
PLoS One. 2026;21:e0345354.
PubMed Abstract available

ZHANG Y, Zhang Y, Zhao C, Xu X, et al
Quantitative assessment of china's policies on the online sale of prescription drugs.
PLoS One. 2026;21:e0358484.
PubMed Abstract available

AICHBERGER MC, Fetz K, Leong S, Kim HS, et al
Discrimination and technology-based disease control.
PLoS One. 2026;21:e0357004.
PubMed Abstract available

FERNANDEZ-PINEDA M, Swift A, Dolbier C, Swanson M, et al
Navigating grief and healthcare: Mixed-methods study on patient experiences of miscarriage during COVID-19.
PLoS One. 2026;21:e0359158.
PubMed Abstract available

BIR C, Widmar NO, Wolf CA, Sheridan T, et al
Societal values versus individual rights with respect to public health related practices during the COVID-19 pandemic in the U.S.
PLoS One. 2026;21:e0358741.
PubMed Abstract available

Proc Natl Acad Sci U S A

MAROUGKA K, Leiva-Rebollo R, Hofma F, van Dijk A, et al
Substitutions affecting the HA-NA-receptor balance preceded the emergence of the pandemic 2009 H1N1 virus.
Proc Natl Acad Sci U S A. 2026;123:e2609870123.
PubMed Abstract available

Vaccine

SCHAFFNER W, Gravenstein S, Kissler S, Cornely OA, et al
Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults.
Vaccine. 2026;93:129082.
PubMed Abstract available

Virology

ROWE T, Ross TM
Transcriptional decoupling of the epithelial-immune bridge is associated with suboptimal influenza B virus immunogenicity.
Virology. 2026;625:111075.
PubMed Abstract available

Virus Res

WU Q, Wang ZZ, Wang ZM, Wang YH, et al
Development and validation of a broadly cross-reactive polyclonal antibody as capture antibody for pan human beta coronavirus antigen detection.
Virus Res. 2026;372:199786.
PubMed Abstract available

MANEESRIWONGUL W, Deesamer S, Butsing N
Factors influencing Thai parents' COVID-19 vaccine acceptance for their children: Vaccine attitudes, beliefs, and children's past influenza vaccination.
Virus Res. 2026 Sep 20:199805. doi: 10.1016/j.virusres.2026.199805.
PubMed Abstract available

JANG Y, Cha RM, Park MJ, Kim JM, et al
Genetic Diversity of Clade 2.3.4.4b H5Nx High Pathogenicity Avian Influenza Viruses Detected in Korea During the 2025-2026 Winter Season and Pathogenicity of H5N1 and H5N9 Viruses.
Virus Res. 2026 Sep 22:199807. doi: 10.1016/j.virusres.2026.199807.
PubMed Abstract available

Giuseppe Michieli

Monday, September 21, 2026

Limited added #benefit of seasonal #influenza #vaccination before #H5 vaccination in mice and #ferrets challenged with #H5N1

ABSTRACT

Limited A(H5)-specific vaccine supply is expected early in a potential A(H5N1) pandemic, raising the question of whether licensed seasonal influenza vaccines could enhance protection when administered before A(H5) vaccination. We evaluated this strategy in mouse and ferret models using clade 2.3.4.4b A(H5N1) viruses. Seasonal influenza vaccination induced antibodies to seasonal haemagglutinins but did not induce detectable antibodies against A(H5) and did not consistently enhance A(H5)-directed antibody responses after A(H5) vaccination. In lethal challenge studies, seasonal vaccine priming before A(H5) vaccination was associated with improved outcomes compared with A(H5) vaccination alone in one of three mouse experiments, but this effect was not observed in the other two mouse experiments or in ferrets. These findings suggest that seasonal influenza vaccine priming provides limited added benefit to A(H5) vaccine-mediated protection against A(H5N1) under the conditions tested.

Source:

Link: https://doi.org/10.1080/22221751.2026.2731495

____

Giuseppe Michieli

Saturday, September 19, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 19 '26)

Arch Virol

SEO H, Rauf A, Seo SH
Enhanced induction of inflammatory cytokines in human lung cells infected with highly pathogenic recent H5N1/2024 avian influenza virus.
Arch Virol. 2026;171:278.
PubMed Abstract available

BMC Pediatr

MAITITUERSUN Y, Su R, Yang G, Taerken AY, et al
A longitudinal study on differential impacts of the COVID-19 pandemic and normalized prevention and control on overweight and obese adolescents in China.
BMC Pediatr. 2026;26:882.
PubMed Abstract available

O'SHEA TM, McGrath M, Douglas J, Blackwell CK, et al
Child health-related behaviors, social connectedness, and impact of the COVID-19 pandemic on children born preterm in the ECHO Cohort.
BMC Pediatr. 2026 Jul 20. doi: 10.1186/s12887-026-07337.
PubMed Abstract available

Cell

WU Q, Seydlitz LM, Iakimov V, Hsu DJ, et al
Dietary arginine drives codon-dependent MHC class I translation and improves immunity in colon tumorigenesis and respiratory viral infection.
Cell. 2026;189:6012-6023.
PubMed Abstract available

Eur J Epidemiol

KOSTER EAS, Sluiskes MH, Putter H, Rosendaal FR, et al
Dynamics of infection, vaccination and excess mortality during the COVID-19 pandemic among older individuals-a nationwide analysis.
Eur J Epidemiol. 2026;41:869-880.
PubMed Abstract available

LEHNER CT, Anastasova I, Schauberger G, Eberl M, et al
Increasing incidence of type 1 diabetes in children and adolescents from 2012 to 2021 in Germany: trends before and during the COVID-19 pandemic.
Eur J Epidemiol. 2026;41:881-892.
PubMed Abstract available

J Gen Virol

ROSS RA, Walsh SK, Montgomery H, Chen H, et al
Bovine mammary tissues are susceptible to infection by viruses bearing panzootic H5N1 influenza A virus glycoproteins.
J Gen Virol. 2026;107:002338.
PubMed Abstract available

J Infect

HARRIS R, Thirard R, Iftikhar H, Middleditch A, et al
Corrigendum to "Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: A randomised controlled trial" [J Infect 93 (2026) 106784].
J Infect. 2026;93:106853.
PubMed

PLoS Biol

VALENCA-PEREIRA F, Johnson B, DeGregori J, Rincon M, et al
Does acute inflammation triggered by infection promote cancer progression?
PLoS Biol. 2026;24:e3003962.
PubMed Abstract available

PLoS Comput Biol

D'AVANZO M, Myint AP, Cacciapaglia G, Hohenegger S, et al
From sequences to strategies: Early detection of new SARS-CoV-2 variants via genetic distance to reduce hospitalizations.
PLoS Comput Biol. 2026;22:e1014707.
PubMed Abstract available

PLoS One

YANG SL, Liu MT, Huang HH, Lin SW, et al
Epidemiology of human RSV in Taiwan, 2018-2024.
PLoS One. 2026;21:e0357769.
PubMed Abstract available

WOLSKO C, Marino E
Incorporating public values into public health communications: Effects of value affirmations on intentions to vaccinate and trust in the U.S.
PLoS One. 2026;21:e0356783.
PubMed Abstract available

FUENTES K, Jacobson D, Birze A, Cadel L, et al
Building capacity in health systems with and for caregivers: A photovoice protocol.
PLoS One. 2026;21:e0358550.
PubMed Abstract available

LI Q, Tang Y, Shi Y, Wu Y, et al
Census-based adolescent depression risk assessment: A novel method and reflections.
PLoS One. 2026;21:e0357661.
PubMed Abstract available

VENKATESAN S, White L, Koo HN, Dickerson J, et al
Estimating cumulative incidence from partially missing time series of respiratory viral infections.
PLoS One. 2026;21:e0353681.
PubMed Abstract available

AKTAS N, Ersoy A, Oruc A, Ortac H, et al
Attitudes, perceptions, behaviours, and concerns of patients listed for kidney transplantation during the COVID-19 pandemic.
PLoS One. 2026;21:e0358328.
PubMed Abstract available

AL-MAGABLEH M, Muhaisen AHM, Ateir RM, Abu Eraq SA, et al
Herbal or conventional medicine? A cross-sectional study of Jordanian university students' preferences for cold and flu treatment.
PLoS One. 2026;21:e0358179.
PubMed Abstract available

SUERDEM A, Zdravkov S, Ivanov MJ
Beyond deficit and coexistence: Modeling the knowledge-conspiracy-mistrust configuration in public understanding of science.
PLoS One. 2026;21:e0341946.
PubMed Abstract available

GWANZURA TNR, Trepka MJ, Li T, Juhasz L, et al
COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study.
PLoS One. 2026;21:e0358543.
PubMed Abstract available

DE VERAS BMG, Michelin L, Croda J, Berra TZ, et al
Burden of respiratory syncytial virus (RSV) hospitalizations among adults aged 60 years or more in Brazil: A retrospective surveillance database analysis (2013-2024).
PLoS One. 2026;21:e0357303.
PubMed Abstract available

Vaccine

HOEN L, Lartey S, Pathirana RD, Cox RJ, et al
Elucidating the role of pre-existing immunity in mucosal lymphoid architectural dynamics following live attenuated influenza vaccination.
Vaccine. 2026;92:129139.
PubMed Abstract available

GUO J, Dai C, Huang Y, Dai J, et al
Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys.
Vaccine. 2026;92:129137.
PubMed Abstract available

LAOHARATTANAHIRUN N, Kiertiburanakul S, Boonnak K, Bruminhent J, et al
Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial.
Vaccine. 2026;92:129166.
PubMed Abstract available

OSTROWSKY JT, Gellin BG, Cavaleri M, Bresee JS, et al
Innovation, development, and licensure of improved influenza vaccines: the way forward.
Vaccine. 2026;92:129135.
PubMed Abstract available

ZHOU B, Wang J, Knote C
Seasonal influenza vaccination coverage and population health burden in Europe during the 2019/2020 and 2021/2022 influenza seasons: an ecological panel analysis using principal-component-adjusted multivariable regression.
Vaccine. 2026;92:129163.
PubMed Abstract available

Giuseppe Michieli

Sunday, September 13, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 13 '26)

Antimicrob Agents Chemother

PENG Z, Yuan H, Huang J, Lin X, et al
A novel ursodeoxycholic acid derivative exhibits broad-spectrum antiviral activity against influenza A virus and coronaviruses by multiphasic disruption of the viral life cycle.
Antimicrob Agents Chemother. 2026 Sep 9:e0028426. doi: 10.1128/aac.00284.
PubMed Abstract available

BMC Pediatr

BOZZOLA E, Piccotti E, D'Auria E, Trapani S, et al
RESPIRIAMO - Italian hospital surveillance for lower respiratory tract infections: a multicenter retrospective cohort study of respiratory syncytial virus-associated hospitalizations in children under 2 years of age.
BMC Pediatr. 2026;26:853.
PubMed Abstract available

J Infect

ZHU X, Deng Y, Xiao G, Zhang J, et al
Re-emergence of H10N3 Avian Influenza Viruses in China: Evolutionary Dynamics and Emerging Zoonotic Risk.
J Infect. 2026 Sep 7:106848. doi: 10.1016/j.jinf.2026.106848.
PubMed

J Virol Methods

EZEANYAEGBU CN, Toledo NP, Corkum CP, Nelder M, et al
Evaluation of one-step amplicon-based targeted enrichment for SARS-CoV-2 whole-genome sequencing using the Midnight amplicon scheme.
J Virol Methods. 2026;346:115448.
PubMed Abstract available

KAZEMIAN S, Pedroza S, Santana-Pereira ALR, Neasham PJ, et al
An enhanced multisegment RT-PCR method for influenza A virus sequencing: Improved performance and reduced preparation time over traditional methods.
J Virol Methods. 2026;347:115453.
PubMed Abstract available

PLoS Comput Biol

QUILTY BJ, Chapman LAC, Munday JD, Wong KLM, et al
Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates.
PLoS Comput Biol. 2026;22:e1014715.
PubMed Abstract available

SONG P, de Vlas SJ, Emery T, Coffeng LE, et al
Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions.
PLoS Comput Biol. 2026;22:e1014721.
PubMed Abstract available

PANT B, Lalovic M, Kiss IZ, Santillana M, et al
The paradox of neglecting changes in behavior: How standard epidemic models misestimate both transmissibility and final epidemic size.
PLoS Comput Biol. 2026;22:e1014746.
PubMed Abstract available

YUAN Z, Zhang X, Lin G, Zou Q, et al
AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning.
PLoS Comput Biol. 2026;22:e1014703.
PubMed Abstract available

BENHAMOU W, Howerton E, Park SW, Viboud C, et al
Leveraging perturbations to infer the population dynamics of human rhinovirus and interaction of influenza A virus.
PLoS Comput Biol. 2026;22:e1014784.
PubMed Abstract available

PLoS Med

LENGLART L, Titomanlio L, Alberti I, Almeida L, et al
Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.
PLoS Med. 2026;23:e1005223.
PubMed Abstract available

PLoS One

KWON K, Jang CY, Kim W, Son J, et al
Kinetics of the PASC Index in Long COVID.
PLoS One. 2026;21:e0357670.
PubMed Abstract available

BATTU S, Moore AR, Lebold K, Pacheco-Navarro A, et al
Outcomes of immunocompromised and non-immunocompromised patients in the ICU diverge late in the pandemic.
PLoS One. 2026;21:e0357181.
PubMed Abstract available

JI M, Dong H, Xu Y, Wang Y, et al
Development of a multiplex real-time PCR assay with fluorescence probe-melting-curve analysis for one-tube detection of respiratory pathogens.
PLoS One. 2026;21:e0357377.
PubMed Abstract available

GONG X, Liu L, Lu Y, Zhang G, et al
Sleepless in America: A social sensing study of pandemic-era sleeplessness using nighttime social media data.
PLoS One. 2026;21:e0356547.
PubMed Abstract available

BHATIA A, Elser J, Carrell SJ, Kronmiller B, et al
Correlation assessment of SARS-CoV-2 variants and their subvariants present in clinical and wastewater samples in Oregon, USA (February 7, 2021 - February 26, 2022) using the Freyja bioinformatics approach.
PLoS One. 2026;21:e0357591.
PubMed Abstract available

MOHD YUSOFF H, Yew SQ, Mohd Nawi A, Mohd Tohit N, et al
Prevalence and risk factors of adverse work outcomes among manufacturing workers with Long COVID in Malaysia - A nationwide study.
PLoS One. 2026;21:e0357125.
PubMed Abstract available

VALDES-LOPEZ JF, di Filippo D, Penagos S, Hernandez-Sarmiento LJ, et al
SARS-CoV-2 infection induces functional impairment of vitamin D receptor signaling to drive interleukin 6-dependent hyperinflammation in mononuclear phagocytes.
PLoS One. 2026;21:e0357030.
PubMed Abstract available

AMARSANAA J, Nguyen TXT, Khan MSR, Kadoya Y, et al
The dynamics of loneliness: A longitudinal exploration of transitions in Japan across the COVID-19 period, 2020-2024.
PLoS One. 2026;21:e0358269.
PubMed Abstract available

Proc Natl Acad Sci U S A

LI L, Nguyen L, Qu H, Wu Q, et al
Increased receptor binding and spike glycosylation, remodeled immune escape of surging SARS-CoV-2 subvariant BA.3.2.2/RE.2.2/Cicada.
Proc Natl Acad Sci U S A. 2026;123:e2614163123.
PubMed Abstract available

Vaccine

BUCKLIN R, Gauthreaux N, Faber E, Askelson N, et al
Listening to micropolitan community leaders to support pandemic response efforts.
Vaccine. 2025;60 Suppl 1:127255.
PubMed Abstract available

HOLLIDAY RC, Darkwa A, Brooks GA, Akintobi TH, et al
Developing counter-narratives to address COVID-19 misinformation among 18-24 year olds in community and campus settings.
Vaccine. 2025;60 Suppl 1:127135.
PubMed Abstract available

HEIMAN SL, Geiger N
Overestimation of racial ingroup worry about the COVID-19 vaccine and medical racism.
Vaccine. 2026;91:129046.
PubMed Abstract available

DUTTA S, Ngemera D, Jaillard P, Juneja S, et al
Lessons learnt from one-year cold chain support for COVID-19 vaccination in 5 middle income countries of North Africa.
Vaccine. 2026;91:128994.
PubMed Abstract available

CAMPBELL STATLER M, Bishop-Royse J, Sampson AT, Martin M, et al
Heterogeneity among the vaccine hesitant: A secondary analysis of the national CEAL Common Survey data.
Vaccine. 2026;91:129024.
PubMed Abstract available

KIM SJ, Kim HW, Son SE, Song JH, et al
Wuhan-ancestral multi-antigen SARS-CoV-2 virus-like particles protect against the omicron sublineage JN.1 variant.
Vaccine. 2026;91:129059.
PubMed Abstract available

FAHFOUHI Y, Fievez S, Cohen R, Levy C, et al
A health-economic assessment of the impact of different RSVpreF maternal vaccine strategies to prevent RSV infections among young infants, in France: EPIPACT.
Vaccine. 2026;91:129036.
PubMed Abstract available

BERIKOPOULOU MM, Tatsi EB, Siahanidou T, Michos A, et al
Systematic review of the mutations in the active antigenic site O of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.
Vaccine. 2026;91:129069.
PubMed Abstract available

NUNES JPDS, Daher IP, Pires ADS, Yamamoto MM, et al
Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.
Vaccine. 2026;91:129073.
PubMed Abstract available

MONOI A, Endo A, Kriznar M, Suzuki M, et al
Comparing the potential impacts of seasonal immunisation against year-round immunisation to prevent RSV infant hospitalisations in Japan: A modelling study.
Vaccine. 2026;91:129079.
PubMed Abstract available

SCHRARSTZHAUPT IN, Diaz-Quijano FA
Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6 months to 4 years in Brazil: A population-based cohort study (2023-2024).
Vaccine. 2026;91:129096.
PubMed Abstract available

ALAMI A, Lewis M, El-Chaar D, Walker M, et al
Maternal vaccination with RSVpreF and risk of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
Vaccine. 2026;91:129070.
PubMed Abstract available

DENG L, Ye X, Chen X, Hu X, et al
Secretory expression of tetrameric neuraminidase enhanced by signal peptide optimization elicits robust immunity against influenza infection in mice.
Vaccine. 2026;92:129118.
PubMed Abstract available

SANBORN J, Robertson MM, Penrose K, Rane M, et al
Gaps between willingness and uptake of influenza and COVID-19 vaccines during the 2025-26 respiratory virus season in a U.S. adult cohort.
Vaccine. 2026;92:129126.
PubMed Abstract available

LU J, Ouyang Z, Huang F, Xie X, et al
Real-world effectiveness of the influenza vaccine among school-aged children in Shenzhen, China, 2024-2025 season: A test-negative design study.
Vaccine. 2026;92:129100.
PubMed Abstract available

THAKKAR V, Aryan Y, Gautam S, Joshi R, et al
Influence of vaccine delivery route on immune imprinting in influenza vaccination.
Vaccine. 2026;92:129109.
PubMed Abstract available

TORAIH EA, Hussein MH, Thomas SJ, Aiash H, et al
Cardiac outcomes following SARS-CoV-2 infection versus BNT162b2 vaccination in adolescents and young adults: a cohort study of 4 million individuals.
Vaccine. 2026;91:129001.
PubMed Abstract available

CABURNAY CA, Fu QJ, Carter T, Butler T, et al
Identification of best outreach strategies and delivery modalities for population subgroups for COVID-19 vaccination.
Vaccine. 2026;60 Suppl 1:128721.
PubMed Abstract available

CANACA G, Vicuna B, Hess JM, Cruz TH, et al
From engagement to ownership: a qualitative study of a community-academic partnership to promote COVID-19 vaccine confidence among Latino/Hispanic communities in New Mexico.
Vaccine. 2026;60 Suppl 1:128583.
PubMed Abstract available

STIEHL E, Negrete M, Flores G, Federmeyer L, et al
Empowering communities during the COVID-19 pandemic: insights from trusted messengers about their work addressing COVID-19 vaccine hesitancy.
Vaccine. 2026;60 Suppl 1:128559.
PubMed Abstract available

NUNO T, Soto S, Sepulveda R, Sierra LA, et al
The Arizona prevention research center vaccine confidence network: A Mobile health unit intervention and survey results of barriers and facilitators to COVID-19 vaccination.
Vaccine. 2025;60 Suppl 1:127970.
PubMed Abstract available

HARA-HUBBARD KK, Beaulieu A, Mendiola A, Gandhi P, et al
Strategies for addressing COVID-19 vaccine equity with intermediaries, prevention research centers, and the vaccine confidence network.
Vaccine. 2025;60 Suppl 1:127847.
PubMed Abstract available

CHUVILEVA YE, Kuiper NM, Ramakrishnan A, Goodman K, et al
Weaving a public health network: Process and results from an evaluation of CDC's Prevention Research Centers Vaccine Confidence Network.
Vaccine. 2025;60 Suppl 1:127636.
PubMed Abstract available

ALMUKHTAR S, McWhirter N, Mendiola A, Samuel S, et al
Exploring lingering COVID-19 vaccine hesitancy in three diverse U.S. states: Alabama, Illinois, and Texas.
Vaccine. 2025;60 Suppl 1:127664.
PubMed Abstract available

BEAULIEU A, LaMonaca K, Higginbottom J, Foster J, et al
Utilizing the Program Impact Pathways framework for improving COVID-19 vaccine confidence and uptake: demonstrations of multi-sector collaboration from two geographies in Connecticut.
Vaccine. 2025;60 Suppl 1:127623.
PubMed Abstract available

JEFFERS A, Kuiper NM, Ramakrishnan A, Swarna H, et al
Building trust in community-academic partnerships: Strategies for enhancing vaccine confidence and demand - Lessons from Prevention Research Centers.
Vaccine. 2025;60 Suppl 1:127624.
PubMed Abstract available

MCGEE RE, Barrett DA, Bednarczyk RA, Grant-Whitlock M, et al
Engaging rural and non-Hispanic Black persons in conversations about the COVID-19 vaccine: a process evaluation of a natural helper intervention.
Vaccine. 2025;60 Suppl 1:127587.
PubMed Abstract available

BORG A, Goulding M, Minkah P, Perrone D, et al
Promotion of COVID-19 vaccination for youth and families in Worcester, Massachusetts: a Diffusion of Innovations approach.
Vaccine. 2025;60 Suppl 1:127586.
PubMed Abstract available

SAVAS LS, Cuccaro P, Zhang K, Hernandez R, et al
Factors influencing COVID-19 vaccine uptake among vulnerable communities in Texas: Perceptions of 2-1-1 helpline callers.
Vaccine. 2025;60 Suppl 1:127554.
PubMed Abstract available

TOTZKAY D, Fraustino JD, Costello LM, Jarrett T, et al
Building on West Virginia's innovative COVID-19 public health communication: associations between vaccination beliefs and vaccination messaging, partisanship, and social vulnerability.
Vaccine. 2025;60 Suppl 1:127555.
PubMed Abstract available

O'CONNOR MH, Nyman AL, Ali S, Rothenberg R, et al
Increasing vaccine uptake in a refugee resettlement community with high social vulnerability.
Vaccine. 2025;60 Suppl 1:127552.
PubMed Abstract available

STIEHL E, Borg A, Cullen JP, Mendiola A, et al
Engaging trusted messengers in public health response: Key strategies to building community trust among CDC'S prevention research center's vaccine confidence network.
Vaccine. 2025;60 Suppl 1:127474.
PubMed Abstract available

HARA-HUBBARD KK, Flores Moreno MG, Sanchez M, Abdi N, et al
The partnership for vaccine confidence: community-academic partnerships to promote COVID-19 vaccines to underserved urban and rural communities using the listen, plan, act, evaluate process.
Vaccine. 2025;60 Suppl 1:127487.
PubMed Abstract available

MALLICK K, Handunge VL, Emmons KM, Blondet L, et al
Engaging a community health ambassador model to promote COVID-19 vaccine in three Massachusetts communities.
Vaccine. 2025;60 Suppl 1:127464.
PubMed Abstract available

Virology

ISHIGAKI H, Otaki K, Kitagawa N, Ishida H, et al
Pathogenicity of SARS-CoV-2 Omicron subvariants JN.1, EG.5.1, and BA.2.86.1 in immunologically naive cynomolgus macaques.
Virology. 2026;624:111036.
PubMed Abstract available

LIU Z, Fan M, Zheng Y, Zeng Y, et al
Transcriptome screening identifies circRNA-INSR as a novel host factor associated with avian influenza virus replication.
Virology. 2026;625:111072.
PubMed Abstract available

MILLER AK, Heremia L, Waller SJ, Blanchard SL, et al
Evaluating sampling strategies for the detection of avian influenza viruses in the environment.
Virology. 2026;625:111069.
PubMed Abstract available

Virus Res

ZHAO Y, Fan H
Clinical impact of baloxavir-induced PA I38T/M substitutions in diverse influenza populations: a systematic review and meta-analysis.
Virus Res. 2026;373:199797.
PubMed Abstract available

Giuseppe Michieli

ETIDIOH - NEW

Saturday, October 17, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 17 '26)

The #Risk of an #H5N1 #Influenza #Pandemic

Saturday, October 10, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 10 '26)

Saturday, October 3, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Oct. 3 '23)

Saturday, September 26, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 26 '26)

Monday, September 21, 2026

Limited added #benefit of seasonal #influenza #vaccination before #H5 vaccination in mice and #ferrets challenged with #H5N1

Saturday, September 19, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 19 '26)

Sunday, September 13, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, September 13 '26)

My New Space

Most Popular Posts